Anemia Warning Backs Medicare

Courtesy Headlines from the Associated Press  Fri, 03/14/2008 - 15:09

WASHINGTON (AP) -- Medicare officials infuriated lawmakers and oncologists last year by limiting when the government would pay for anemia drugs used by cancer patients.

Now, an advisory committee suggests even more limits on the drugs....

Tags:

 

More related items

Medicare to pay for $93,000 prostate cancer drug
WASHINGTON (AP) -- Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the...

Dendreon trades higher on prostate drug review
WASHINGTON (AP) -- Shares of biotech drugmaker Dendreon jumped Thursday after Medicare officials issued a mostly positive assessment of the company's prostate cancer therapy, setting the...

ASH: IV Iron Fails Test in Cancer-Related Anemia...
NEW ORLEANS (MedPage Today) -- Intravenous iron supplementation failed to boost the benefits of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia,...

Burt's Bees Free Head to Toe Starter Kit

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com